Humana (HUM) Cash from Operations (2009 - 2026)

Humana (HUM) has reported Cash from Operations for 18 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations rose 54.68% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 13.4% decrease from a year earlier, with the FY2025 full-year figure at $921.0 million, down 68.95% from the prior year.
• Cash from Operations was $2.0 billion for Q2 2026 at Humana, up from $1.3 billion in the prior quarter.
• Over five years, Cash from Operations peaked at $8.5 billion in Q3 2022 and troughed at -$7.1 billion in Q4 2023.
• A 5-year average of $870.8 million and a median of $1.1 billion in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 5240.62% in 2022 and soared 2114.24% in 2023, its largest moves.
• Over 5 years, Cash from Operations stood at -$5.1 billion in 2022, then tumbled by 39.15% to -$7.1 billion in 2023, then surged by 92.6% to -$528.0 million in 2024, then plunged by 212.88% to -$1.7 billion in 2025, then soared by 219.01% to $2.0 billion in 2026.
• The last three Cash from Operations figures came in at $2.0 billion (Q2 2026), $1.3 billion (Q1 2026), and -$1.7 billion (Q4 2025), per Business Quant data.